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Recent cross-sectional data suggest that better vitamin K status in young girls (aged 3–16 years) is associated with decreased bone turnover, even
though it is not associated with bone mineral content (BMC). The objective of the present study was to investigate the relationship between serum
percentage of undercarboxylated osteocalcin (%ucOC), as an index of vitamin K status, and BMC and biochemical indices of bone turnover in
peri-pubertal Danish girls. This peri-pubertal stage is a dynamic period of bone development, and as such, may represent an important window
of opportunity for vitamin K status to modulate childhood bone health. Serum %ucOC and serum 25-hydroxyvitamin D (25 (OH) D) were
measured at baseline in a study of 223 healthy girls aged 11–12 years. Urinary pyridinium crosslinks of collagen and serum total osteocalcin
as markers of bone resorption and formation, respectively, as well as BMC (total body and lumbar spine) were also measured. Serum %ucOC
(median 21·9 %) was not associated with markers of bone resorption or with total osteocalcin. Serum %ucOC was inversely correlated with
serum 25 (OH) D (r 20·143; P,0·05). Serum %ucOC was negatively associated with BMC of the total body (b 20·045; P,0·001) and
lumbar spine (b 20·055; P,0·05), after adjustment for potential confounders including vitamin D status. Better vitamin K status was associated
with increased BMC, but not bone turnover, in healthy peri-pubertal Danish girls. There is a need for well-designed, randomized phylloquinone
supplementation trials in children and adolescents to confirm epidemiological findings of an association between vitamin K status and bone health.
Undercarboxylated osteocalcin: Vitamin K: Bone mineral content: Bone turnover: Adolescent girls
Vitamin K is a cofactor for the vitamin K-dependent carboxy-
lase, a microsomal enzyme that facilitates the post-transla-
tional conversion of glutamyl to g-carboxyglutamyl residues
(Esmon et al. 1975). Its classic role in this respect involves
the synthesis of several coagulation factors, including
plasma procoagulants, prothrombin (factor II) and factors
VII, IX and X and anticoagulants (proteins C and S) (Shearer,
1990, 2000; Food & Nutrition Board, Institute of Medicine,
2001). The maintenance of plasma prothrombin concentrations
was the basis for the recommended dietary intake value of
1mg/kg body weight per d, set by the National Research
Council in 1989 in the USA and by the Department of
Health in 1991 in the UK. The current US recommended ade-
quate intakes for vitamin K are 55–75mg/d for children,
which are based on median intakes for children in the third
National Health and Examination Survey (Food & Nutrition
Board, Institute of Medicine, 2001).
More recently, the identification of g-carboxyglutamyl-con-
taining proteins in bone, notably osteocalcin and matrix
g-carboxyglutamyl protein (also known as matrix Gla pro-
tein), has generated much interest in the role of vitamin K
in bone metabolism and bone health (Binkley & Suttie,
1995; Vermeer et al. 1995; Food & Nutrition Board, Institute
of Medicine, 2001; Weber, 2001). Furthermore, it has been
suggested that dietary phylloquinone (vitamin K1) levels that
are sufficient to maintain normal blood coagulation may be
sub-optimal for adult bone health (Kohlmeier et al. 1996;
Vermeer et al. 1996; Sokoll et al. 1997).
The circulating concentration of under-g-carboxylated
osteocalcin (ucOC), a sensitive marker of vitamin K nutri-
tional status (Sokoll & Sadowski, 1996), has been reported
to be a marker of hip fracture risk and a predictor of bone min-
eral density (BMD) (Vermeer et al. 1992; Szulc et al. 1993,
1994, 1996; Jie et al. 1996; Booth et al. 2000, 2003; Kaneki
et al. 2001; Sugiyama & Kawai, 2001). Moreover, the findings
of two large, prospective cohort studies: the Nurses’ Health
Study (Feskanich et al. 1999) and the Framingham Heart
Study (Booth et al. 2000), support an association between
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relative risk of hip fracture and phylloquinone intake. Further-
more, Booth et al. (2003) recently reported that adult women
(from the Framingham Heart Study) in the lowest quartile of
phylloquinone intake (,70mg/d) had significantly lower
(P , 0·005) mean BMD of the femoral neck and spine than
did those in the highest quartile of phylloquinone intake
(309mg/d), an association which was not evident in men.
There has been much less research emphasis on the influ-
ence of vitamin K on bone health in earlier life. This is despite
the fact that there is evidence that phylloquinone intakes in
many children/adolescents are below the recommended level
(Booth et al. 1996; Thane et al. 2002; Pyrnne et al. 2005;
Collins et al. 2006). Gaining an understanding of the role of
vitamin K in bone metabolism and bone mass in early life is
important, because finding new strategies to maximize the
accretion of bone during growth may help reduce the risk of
osteoporosis in later life (Kalkwarf et al. 2004). Recently,
Kalkwarf et al. (2004) investigated the effect of vitamin K
intake and status on bone turnover and bone mass in healthy
young girls (aged 3–16 years) in the USA. This is the first
study to examine the relationship between vitamin K nutritive
status and bone health in children. Their findings suggest that
better vitamin K status (as assessed by plasma phylloquinone
and serum percentage of undercarboxylated osteocalcin
(%ucOC)) was associated with decreased bone turnover,
even though it was not associated with baseline BMC. Further-
more, while serum %ucOC was not associated with 4-year
changes in BMC of the hip, total body, or total body minus
the head, somewhat surprisingly, serum %ucOC was posi-
tively (P¼0·001) associated with 4-year changes in lumbar
spine BMC. The girls in the Kalkwarf et al. (2004) study,
however, were aged 3–16 years, representing a broad span
in terms of skeletal and sexual maturity.
Therefore, the objective of the present study was to investi-
gate the relationship between serum %ucOC, as an index of
vitamin K status, and BMC and biochemical indices of bone
turnover in 223 Danish girls, aged 11–12 years. This peri-
pubertal stage is a dynamic period of bone development,
and as such, may represent an important window of opportu-
nity for vitamin K status to modulate childhood bone health.
Subjects and methods
Subjects
A total of 225 Danish girls, aged between 10·9 and 11·9 years,
were recruited for participation in a 12-month vitamin D inter-
vention trial on bone health (as part of the Optimal Strategy
for Vitamin D Fortification (OPTIFORD) project; www.opti-
ford.org) and the BMC and urinary pyridinium crosslink
data reported in the present work were the baseline values
from that intervention study. Subjects were recruited using
information from the Danish National Central Offices of
Civil Registrations, which allowed us identify the names and
addresses of all girls born in Denmark with Danish citizenship,
aged 10·0–11·0 years, living in the municipals of Copenhagen
and Frederiksberg (n 1755). In order to minimize age differ-
ences at inclusion, the oldest subjects were recruited first
and we continued until 225 had agreed to participate, corre-
sponding to 22 % of the 1009 who were asked to participate
by mail. Of the 225 girls participating in the intervention
trial, serum %ucOC data (as determined by assessment of
serum total osteocalcin and ucOC) were successfully derived
for 223 girls and these were included in the present work.
The study was approved by the Research Ethical Committee
of Copenhagen and Frederiksberg (J.nr (KF) 01-129/01).
Informed consent was obtained from the parent/guardian of
each participant. Girls were excluded on the basis of the fol-
lowing criteria: chronic diseases; intake of drugs that could
influence bone metabolism; daily intake of calcium sup-
plements or vitamin/mineral supplements
Design
This was an association study which examined the relationship
between bone status indices (BMC and biochemical markers
of bone turnover) and %ucOC, as a widely used marker of
vitamin K status (Sokoll et al. 1997), in a cohort of healthy
young Danish girls, aged 10·9–11·9 years. Subjects were
instructed to collect urine samples between 08.00 and 10.00
hours after an overnight fast. In addition, after an overnight
fast, a blood sample (10 ml) was also taken between 08.00
and 10.00 hours from each subject. On the same day as
blood and urine sampling, each girl, with the help of their
parent/guardian and a trained researcher, completed various
questionnaires, including a general health and lifestyle ques-
tionnaire, a FFQ, a physical activity questionnaire and a pu-
bertal status questionnaire. Anthropometric measurements
(weight and height) were also taken at this time.
Assessment of dietary calcium and vitamin D
The subjects filled in, together with their parents/guardians, a
standardized FFQ with twelve questions covering nine food
items that ascertained the foods (including fortified foods)
contributing to 95 % of the vitamin D intake and 75 % of
the calcium intake determined from the most recent dietary
intake studies in Denmark. The questionnaire had nine pre-
determined possible frequencies (ranging from ‘less than one
time per month’ to ‘4–5 times per day or more’). A trained
dietitian checked the completed FFQ, and requested additional
information or clarification on entries, if necessary. The
Danish Institute for Food and Veterinary Research performed
the intake calculations using the General Intake Estimation
System, a system developed at the Institute (Christensen,
2001). The FFQ and calculations used have been reported
earlier (Andersen et al. 2005). Unfortunately, as the FFQ
was tailored for calcium and vitamin D, it could not be used
to estimate phylloquinone intakes.
Pubertal status
The stage of puberty was assessed in each subject ad modum
Tanner (Marshall & Tanner, 1969) by a self-assessment proto-
col based on the evaluation of breast development by pictures
and timing of menarche (J. Mu¨ller et al. unpublished results).
Physical activity
Physical activity was recorded using a 24 h recall
questionnaire (Habitual Activity Estimation Scale; Boucher
et al. 1997), as used previously in young Danish girls
E. O’Connor et al.662
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114507433050
Downloaded from https://www.cambridge.org/core. Mary Immaculate College of Education, on 09 Apr 2018 at 11:11:33, subject to the Cambridge Core terms of use, available at
(Molgaard et al. 2001). In brief, the Habitual Activity Esti-
mation Scale questionnaire records the hours per day spent
on each of four activity levels corresponding to supine pos-
ition (I), sitting (II), walking (III) and running (IV). In the cur-
rent study, hours per day spent on high activity (level IV) was
used as a measurement for activity level, as this has been
shown to correlate well with mean daily activity computer
(Caltrac) measurement (counts/d) during a week (7 d; Mol-
gaard et al. 2001). Activity was recorded during 2 week
days and one weekend day and the mean of the 3 d activity
(level IV) was used in the analyses.
Bone mineral density and bone mineral content
Bone mineral content (BMC; measured in g hydroxyapatite),
bone size (expressed as anterior–posterior projected bone
area (BA); measured in cm2) and BMD (BMD ¼ BMC/BA
in g/cm2) as well as percentage fat and lean body mass content
were measured by dual-energy X-ray absorptiometry using the
Hologic 1000/W scanner (Hologic Inc., Waltham, MA, USA).
The skeletal sites assessed were the whole body and the
lumbar spine (L2–L4). Subjects wore only underpants and a
cotton T-shirt during the scan. For whole body and lumbar
analyses, software version V5.73 and V4.76P, respectively,
were used. For quality control, a spine phantom was scanned
daily. The CV for the BMC, BMD and BA measurements on
the spine phantom over a period of 2 years (n 429) was 0·35,
0·32 and 0·32 %, respectively. In adults examined at 8-week
intervals reproducibility, expressed as CV, was 1·6, 2·2, 0·9,
2·3 and 1·9 % for whole body BMC, BA, BMD, percentage
fat and lean body mass, respectively (D Hansen & A
Astrup, unpublished results). The effective dose for a whole
body and a lumbar dual-energy X-ray absorptiometry scan
was not more than 10mSv in total, equal to about daily back-
ground radiation in Denmark.
Collection and preparation of samples
Subjects were supplied with suitable collection containers for
urine samples and asked to collect morning void urine samples
between 08.00 and 10.00 hours after an overnight fast. Por-
tions of urine were stored at 2208C from the morning of
collection until required for analysis. Blood was collected by
venepuncture into vacutainer tubes with no additive and
were processed to serum, which was immediately stored at
2808C until required for analysis.
Experimental techniques
Serum total and undercarboxylated osteocalcin. Total
(intact) osteocalcin levels, a biomarker of bone formation,
were measured in serum samples using an ELISA (Metrae
Osteocalcin EIA Kit, Quidel Corporation, CA, USA). The
intra- and inter-assay CV were 6·0 and 7·6 %, respectively.
ucOC (a measure of vitamin K status) was measured using
the method of Yan et al. (2004), which is a modification of
that described by Gundberg et al. (1998). In brief, 60ml of
each serum sample was treated with 30ml hydroxyapatite
(15 mg/ml; Calbiochem, Merck Biosciences, Bestor, Nothing-
ham, UK). Samples were shaken for 1 h at room temperature
and then centrifuged for 5 min. ucOC in the supernatants
was quantified using the Metrae Osteocalcin EIA Kit. ucOC
was expressed as the percentage of total osteocalcin
(%ucOC). The intra- and inter-assay CV were 9·5 and
12·8 %, respectively.
Serum 25-hydroxyvitamin D. Serum 25-hydroxyvitamin D
(25 (OH) D) levels were measured by a HPLC-based method,
as described in detail elsewhere (Andersen et al. 2005).
Urinary creatinine, pyridinoline and deoxypyridinoline.
Creatinine was determined in urine samples using a diagnostic
kit (Metrae Creatinine Assay Kit, catalogue no. 8009, Quidel
Corporation). Urine samples were analysed in duplicate for
total pyridinoline (Pyr) and total deoxypyridinoline (Dpyr),
biochemical markers of bone resorption, using an automated
HPLC system, as described in detail elsewhere (Doyle et al.
2005). Urinary Pyr and Dpyr were expressed on a creatinine
basis.
Statistical methods
The distribution of %ucOC and concentrations of urinary pyr-
idinium crosslinks were skewed to the right, so the data were
converted to the natural logarithm prior to analysis. Multiple
regression analysis was used to assess the association between
the biochemical indicator of vitamin K status (serum %ucOC)
and biochemical markers of bone resorption (urinary Pyr and
Dpyr) and bone formation (serum total osteocalcin). Covari-
ates that were considered in these models included age,
Tanner stage, height, weight, dietary calcium intake, vitamin
D status and physical activity because these factors could
theoretically affect the concentrations of the markers of
bone turnover. Covariates were kept in the regression
models for a given marker if they were significantly associated
(P,0·05) with that bone marker for serum %ucOC. Multiple
regression analysis was used to assess the association between
serum %ucOC and BMC of the total body and lumbar spine.
Because of the known size-related effects on estimates of bone
density by dual-energy X-ray absorptiometry, particularly in
children (Nelson & Koo, 1999), we chose to use BMC as
the outcome variable and statistically adjust for BA, by
using the natural logarithm of both, as recommended by Pren-
tice et al. (1994). Potential covariates that were considered in
the regression models of BMC included BA, age, Tanner
stage, height, weight, dietary calcium intake, vitamin D
status and physical activity. For all BMC analyses, regression
models were first run with all relevant covariates, and then a
reduced model that included only those variables that were
associated with the BMC outcome at P,0·05 was fitted.
The relationships between serum %ucOC and serum total
osteocalcin, between serum %ucOC and 25 (OH) D, as well
as between urinary pyridinium crosslinks and serum total
osteocalcin, were assessed using Pearson’s correlation coeffi-
cients. Differences in serum %ucOC and 25 (OH) D among
seasons were assessed using one-way ANOVA. P,0·05 was
considered significant.
Results
Descriptive characteristics of the girls and values for bio-
chemical measures of vitamin K and D status as well as
bone turnover are given in Table 1. The median (mean)
serum 25 OH D concentration and %ucOC were 41·9
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(mean 43·2) nmol/l and 21·9 (mean 22·2) %, respectively, but
there was a wide variation in both status measures (8·5–
93·1 nmol/l and 4·5–58·4 %, respectively).
Serum %ucOC was not significantly correlated with serum
total osteocalcin concentration (r 20·085, P¼0·206). Serum
%ucOC was inversely correlated with serum 25 OH D concen-
tration (r 20·143, P¼0·035). There was a significant seasonal
variation evident in serum 25 OH D concentration
(P,0·0001) and serum %ucOC (P,0·05). Serum total osteo-
calcin was positively correlated with urinary Pyr (r 0·119,
P¼0·049) and urinary Dpyr (r 0·155, P,0·026). As expected,
urinary Pyr and Dpyr were strongly correlated (r 0·768,
P,0·0001).
We examined the relation between %ucOC and markers of
bone turnover and BMC of lumbar spine and total body
(Table 2). There was no association between serum %ucOC
and serum total osteocalcin, and between serum %ucOC and
urinary Pyr and Dpyr, even after adjusting for covariates.
Serum %ucOC was inversely associated with BMC of the
lumbar spine and total body, when adjusted for BA, pubertal
maturation, weight, vitamin D status or dietary calcium.
Discussion
Interest in the role of vitamin K nutritive status in childhood
bone health has heightened in recent times with the findings
that better vitamin K status (plasma %ucOC and phyllo-
quinone concentrations), if not dietary intake, was related to
decreased bone turnover in healthy girls, aged 3–16 years
(Kalkwarf et al. 2004). A reduction in the rate of bone turn-
over, arising from better vitamin K status, would usually cor-
respond to greater bone mass; however, this was not found to
be the case in the study by Kalkwarf et al. (2004). In fact, that
study showed inconsistent, and somewhat unexpected, associ-
ations between vitamin K status and BMC. For example, while
plasma %ucOC or phylloquinone were, in general, not associ-
ated with baseline BMC, plasma phylloquinone was inversely
(P¼0·03) associated with lumbar spine BMC (Kalkwarf et al.
2004). Furthermore, while plasma %ucOC was not associated
with 4-year changes in BMC of the hip, total body, or total
body minus the head, it was positively (P¼0·001) associated
with 4-year changes in lumbar spine BMC (Kalkwarf et al.
2004). In contrast, the present study showed that better vita-
min K status, as indicated by lower %ucOC, was indeed posi-
tively related to BMC of the total body and lumbar spine in a
group of 11–12-year-old girls.
The reasons for the divergent findings between the two
studies are unclear, but may be related to the differences in
age-profile of the study participants. The subjects in the
study by Kalkwarf et al. (2004) were aged 3–16 years, repre-
senting girls in a number of distinct phases of sexual and bone
maturity, whereas the girls in the present study were 11–12
years, and, for the most part, were peri-pubertal. The rate of
increment in BMD can be very pronounced during this
phase of early life (Theintz et al. 1992), and, as such, might
represent a period during which the impact of differences in
vitamin K status on childhood bone mass may be more evi-
dent. Another notable distinction between the two studies
was the inclusion and omission of data on vitamin D status
of the girls in the regression models in the present study and
that of Kalkwarf et al. (2004), respectively. Of note, we
found that serum %ucOC was inversely correlated with
serum 25 (OH) D levels, the most widely used marker of vita-
min D status. This is in line with a similar relationship
reported in elderly women (Szulc et al. 1993). Whether the
relationship between vitamin D status and serum %ucOC is
causal has not been investigated; however, Szulc et al.
(1993) showed that vitamin D plus calcium supplementation
significantly reduced the %ucOC in elderly women. Further-
more, serum %ucOC as well as serum 25 OH D concen-
trations exhibited clear seasonal variation (with lowest and
highest values, respectively, evident in late summer/early
autumn) in these elderly women and in the young adolescent
girls in the present study. Thus, while more research is needed
to define better the relationship between vitamin D and K
status, vitamin D status could be an important confounder in
studies which investigate the role of vitamin K in bone
health. Vitamin D status has important effects on bone
health. Moreover, data from a number of studies in adoles-
cents provide evidence of a possible adverse effect of low
vitamin D status for bone health in early life (Outila et al.
2001; Lehtonen-Veromaa et al. 2002; Cheng et al. 2003).
For example, in a 3-year longitudinal study of Finnish girls
Table 1. Subject characteristics and values for biochemical measures
of vitamin K status and for bone turnover
Median Range
n 223 –
Age (years) 11·4 10·9–11·9
Height (cm) 150·1 130·8–172·0
Weight (kg) 40·0 24·3–84·3
BMI (kg/m2) 17·5 12·7–31·6
Tanner score (%)
1 8·93 –
2 41·52 –
3 48·66 –
4 0·89 –
Physical activity (h/week)* 2·7 0–7·5
Calcium intake (mg/d) 924 83–3538
Serum 25-hydroxyvitamin D (nmol/l) 41·9 8·5–93·1
Serum undercarboxylated osteocalcin (%) 21·9 4·5–58·4
Serum total osteocalcin (ng/ml) 48·7 16·6–110·4
Urinary pyridinoline (nmol/mmol creatinine) 73·4 17·3–262·8
Urinary deoxypyridinoline
(nmol/mmol creatinine)
39·6 13·3–146·0
* Hours per day spent on high activity (level IV) was used as a measurement for
activity level, as this has been shown to correlate well with mean daily activity
computer (Caltrac) measurement (counts/d) during a week (7 d).
Table 2. Associations between serum percentage undercarboxylated
osteocalcin (%ucOC) and biochemical markers of bone turnover and
bone mineral content (BMC) (n 223)*
Serum %ucOC
Bone health index b SE P
Urinary pyridinoline 20·209 0·142 0·143
Urinary deoxypyridinoline 20·072 0·128 0·575
Serum total osteocalcin 20·084 0·060 0·160
BMC total body 20·045 0·017 0·016
BMC lumbar spine 20·055 0·026 0·037
*b, Regression coefficients were generated from natural log-transformed data.
Direct interpretation of the coefficients requires back transformation to original
units. All regression models included pubertal maturation, weight, vitamin D
status, dietary calcium and bone area (for BMC relationships).
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aged 9–15 years, Lehtonen-Veromaa et al. (2002) found that
baseline 25 (OH) D levels were positively correlated with
unadjusted 3-year change in BMD at the lumbar spine
(r 0·35; P,0·001) and femoral neck (r 0·32; P,0·001). Vilja-
kainen et al. (2006) recently showed that vitamin D sup-
plementation of adolescent Finnish girls, mean age 11·4
years, for 12 months significantly increased BMC of femora
and vertebrae. Indeed, there may be an interaction between
vitamin K and D in relation to production of fully functional
osteocalcin (Shearer, 1997), with possible consequences for
bone health. Additionally, while the present study assessed
indices of vitamin K and bone turnover in fasting serum
samples, Kalkwarf et al. (2004) used non-fasting serum
samples.
The association between vitamin K status and BMC in ado-
lescent girls is in line with similar findings in adults. For
example, the circulating concentration of ucOC has been
reported to be a marker of hip fracture risk and a predictor
of BMD in adults (Vermeer et al. 1992; Szulc et al. 1993,
1994, 1996; Jie et al. 1996; Booth et al. 2000, 2003; Kaneki
et al. 2001; Sugiyama & Kawai, 2001). Improving vitamin
K status has been shown in some (Binkley et al. 2000;
Booth et al. 2001), but not all (Braam et al. 2003), interven-
tion studies to reduce the levels of markers of bone turnover
in adults, which might explain the effects of vitamin K
status on bone mass. However, serum %ucOC was not related
to biochemical markers of bone turnover in the present study,
in contrast to the findings of Kalkwarf et al. (2004). The
reasons for these divergent findings are unclear. One possi-
bility is that, as suggested by Kalkwarf et al. (2004), bone
markers may reflect relatively acute effects of vitamin K,
whereas the observed relations between serum %ucOC and
BMC may reflect more longer-term effects on bone.
Unfortunately, we were unable to estimate the habitual
phylloquinone intake in the adolescent girls in the present
study due to limitations in the dietary assessment tool used
in the study. However, dietary phylloquinone has not been
found to be a good predictor of bone turnover or BMC in
healthy girls (Kalkwarf et al. 2004). Not withstanding the
lack of dietary intake data, the girls in the present study had
a relatively high degree of undercarboxylation of serum osteo-
calcin (median 21·9 %), which is within the range reported for
healthy girls from other studies [13·6 % in the USA (aged 3–
16 years; Kalkwarf et al. 2004) and 33·9 % in Ireland (aged
11–12 years; unpublished results from our laboratory)].
There is a major difference, however, between estimates of
circulating %ucOC levels in healthy children and in children
at risk of vitamin K deficiency. For example, Conway et al.
(2005) recently showed that 11-year-old children with cystic
fibrosis had a median %ucOC of 71 %, which may be more
related to vitamin K malabsorption. However, some caution
is warranted when comparing the results of %ucOC from
studies which use different methods of assessing ucOC. For
example, assays based on antibodies against ucOC tend to
overestimate %ucOC compared with its measurement with
hydroxyapatite binding assays (Gundberg et al. 1998). While
our studies (of Danish and Irish adolescent girls) and that of
Kalkwarf et al. (2004) used the hydroxyapatite binding
assay, that of Conway et al. (2005) used the immunoassay.
In conclusion, there is evidence that phylloquinone intakes
in many children/adolescents are below the recommended
level (Booth et al. 1996; Thane et al. 2002; Pyrnne et al.
2005; Collins et al. 2006). The findings of the present study,
and that of Kalkwarf et al. (2004), suggest potentially adverse
effects of low vitamin K status for bone health indices, how-
ever, they do not provide evidence of cause and effect. There-
fore, there is a need for well-designed, randomized
phylloquinone supplementation trials in children and adolescents
to confirm these epidemiological findings of an association
between vitamin K status and bone health.
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